VeruSTU:FMW0 28 OCF Yield % is -53.05 as of Jul. 06, 2026. GuruFocus rates STU:FMW0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,410 Biotechnology companies, Veru ranks worse than 84.54% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Veru's OCF Yield % or its related term are showing as below:
STU:FMW0'
s OCF Yield % Range Over the Past 10 Years
Min: -159.85 Med: -5.88 Max: 2.09
Current: -53.05
During the past 13 years, the highest OCF Yield % of Veru was 2.09%. The lowest was -159.85%. And the median was -5.88%.
STU:FMW0's OCF Yield % is ranked worse than 84.54% of 1410
companies
in the Biotechnology industry
Industry Median: -8.015
vs STU:FMW0: -53.05
Veru's OCF Margin % for the quarter that ended in Mar. 2026 was %.
Veru OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Veru OCF Yield % Related Terms
Veru OCF Yield % Historical Data
* Premium members only.
The historical data trend for Veru's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:FMW0 vs AURX, PDSB, LTRN: OCF Yield % Comparison
For the Biotechnology subindustry, Veru's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veru OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Veru's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Veru's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veru (STU:FMW0) has a OCF Yield % of -53.05 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Veru and its competitors. According to the industry distribution chart, Veru ranks #1192 out of 1410 companies in the Biotechnology industry, placing it in the top 84.5%.
Is Veru's OCF Yield % too high?
Veru's current OCF Yield % is -53.05. Based on the distribution chart, Veru ranks #1192 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Veru has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Veru's OCF Yield % compare to AURX and PDSB?
According to the Biotechnology industry distribution chart, Veru ranks #1192 out of 1410 companies for OCF Yield %. This places Veru in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Veru and its competitors. Veru's current OCF Yield % is -53.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veru stock overvalued right now?
Veru (STU:FMW0) has a current OCF Yield % of -53.05. The current OCF Yield % is -53.05. Veru's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Veru (STU:FMW0), the current OCF Yield % is -53.05 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.
28GF Score
Get the complete analysis for STU:FMW0
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:FMW0 has been successfully added to your 
